Apollomics (APLM) Research Hub

Apollomics (APLM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 23.205 USD (-6.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.46, market cap 0.02B. This hub links to the full technical, earnings and options research available for APLM.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close23.205 USD (-6.73%)
52-week range12.88 USD – 28.29 USD
Trend regimeRange
14-day RSI66.7 (Bullish)
Trailing P/E-2.46
Market cap0.02B
Dividend yield0.00%
Next earnings2026-09-24

Available research for APLM

Earnings

APLM earnings: next report 2026-09-24, real EPS beat/miss history, analyst consensus Buy, P/E -2.46. Updated 2026-07-23.

Options: Covered Call

Covered Call on APLM: how it works, illustrative setup around the real 23.2 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on APLM: how it works, illustrative setup around the real 23.2 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on APLM: how it works, illustrative setup around the real 23.2 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

APLM technical analysis: range, last 23.205 USD, RSI 66.7, 52w range 12.88 USD–28.29 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is APLM in?

Apollomics (APLM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is APLM in an uptrend or downtrend?

As of 2026-09-11, APLM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is APLM's trailing P/E ratio?

APLM's trailing P/E is -2.46, with a market cap of 0.02B. See the earnings research page for full valuation detail.

When does APLM next report earnings?

APLM is next scheduled to report earnings on 2026-09-24.